The FDA released a new guidance titled “Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA) During the COVID-19 Public Health Emergency” on April 30, 2020.
Category Archives: White Papers
Saleable Returns/VRS White Paper
Everyone has been talking about Saleable Returns (and VRS), but do you really understand your options to meet the upcoming requirement? What are the relative costs, implementation complexities,manual efforts, and data security considerations for each potential solution?